Tango Therapeutics: Peers

The FY2025 (Dec) proxy of Tango Therapeutics names 18 peer companies for pay. Among Tango Therapeutics and these peers, CEO pay was 7th highest of 8.

7th highest of 8in Tango Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$2.5M$9.5M

Pay peer group, FY2025 (Dec) proxy

IDEAYA Biosciences
Kymera Therapeutics
Celldex Therapeutics
Cullinan Therapeutics
Kura Oncology
Relay Therapeutics
Keros Therapeutics
Bicycle Therapeutics plcNot disclosedNot disclosed
CARGO Therapeutics, Inc.Not disclosedNot disclosed
Dyne TherapeuticsNot disclosedNot disclosed
Foghorn Therapeutics, Inc.Not disclosedNot disclosed
Merus N.V.Not disclosedNot disclosed
Pliant Therapeutics, Inc.Not disclosedNot disclosed
Repare Therapeutics, Inc.Not disclosedNot disclosed
Replimune Group, Inc.Not disclosedNot disclosed
Syndax PharmaceuticalsNot disclosedNot disclosed
Zentalis Pharmaceuticals, Inc.Not disclosedNot disclosed
iTeos Therapeutics, Inc.Not disclosedNot disclosed
18 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.